Steven Altschuler - 25 Jun 2024 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LXEO	Stock Option (right to buy)	Award	$0	+18,000		$0.000000	18,000	25 Jun 2024	Common Stock	18,000	$16.87	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 25, 2025, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date.